Androgen excess, theca, granulosa, polycystic ovary syndrome, steroidogenesis, folliculogenesis, estrogen, insulin sensitivity, signaling defect. Polycystic ovary syndrome (PCOS) is a common, clinically heterogeneous disorder that affects approximately 6–10% of premenopausal women [1, 2]. Hyperandrogenemia is the biochemical hallmark of PCOS. Reproductive and endocrine abnormalities include disordered gonadotropin secretion, oligomenorrhea and anovulatory infertility, and endometrial hyperplasia. Obesity, hirsutism, acne, and alopecia are often associated with PCOS. The metabolic consequences of PCOS include insulin resistance, lipid abnormalities, and possibly an increased risk of cardiovascular disease [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Wickenheisser, J.K., McAllister, J.M. (2007). Ovarian Steroidogenic Abnormalities in PCOS. In: Azziz, R. (eds) The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care. Endocrine Updates, vol 27. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-69248-7_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-69248-7_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-69246-3
Online ISBN: 978-0-387-69248-7
eBook Packages: MedicineMedicine (R0)